Copyright
©The Author(s) 2019.
World J Gastroenterol. Jun 14, 2019; 25(22): 2788-2798
Published online Jun 14, 2019. doi: 10.3748/wjg.v25.i22.2788
Published online Jun 14, 2019. doi: 10.3748/wjg.v25.i22.2788
Outcome | Immunomodulators | Systemic steroid | Biologic agents | |||
Yes (n = 10199) | No (n = 27497) | Yes (n = 21606) | No (n = 16090) | Yes (n = 2075) | No (n = 35621) | |
Atrial fibrillation | 85 | 263 | 227 | 121 | 21 | 327 |
Incidence rate1 | 1.72 | 1.97 | 2.21 | 1.50 | 2.16 | 1.89 |
Adjusted HR2 (95%CI) | 1.46 (1.13-1.89) | 1 (reference) | 1.37 (1.10-1.71) | 1 (reference) | 2.38 (1.51-3.75) | 1 (reference) |
- Citation: Choi YJ, Choi EK, Han KD, Park J, Moon I, Lee E, Choe WS, Lee SR, Cha MJ, Lim WH, Oh S. Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study. World J Gastroenterol 2019; 25(22): 2788-2798
- URL: https://www.wjgnet.com/1007-9327/full/v25/i22/2788.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i22.2788